Pharvaris

Founded in 2015 and headquartered in Zug, Switzerland, Pharvaris is a clinical-stage pharmaceutical manufacturing company dedicated to developing oral bradykinin-B2-receptor antagonists. The company focuses on novel small molecules targeting this clinically validated pathway, aiming to provide alternatives to injected therapies for all sub-types of hereditary angioedema (HAE) and other bradykinin-mediated diseases. Its team includes the core group behind the discovery and approval of the HAE treatment icatibant, combined with executives bringing broad expertise in pharmaceutical development and rare disorders. With more than 150 employees, Pharvaris continues to advance potent, orally available compounds designed to transform care for patients with bradykinin-mediated conditions.

• 

  Pharvaris

  18 days ago

  Scientific publications lead

  hybrid, Boston, MA, United States

  Full TimeLead / Manager

  Apply
• 

  Pharvaris

  a month ago

  Patient and digital marketing lead

  hybrid, Lexington, MA, United States

  $170k – $210k/yrFull TimeSenior (5+ years)

  Apply
• 

  Pharvaris

  a month ago

  Congress and peer-to-peer lead

  hybrid, Lexington, MA, United States

  $180k – $220k/yrFull TimeSenior (5+ years)

  Apply
• 

  Pharvaris

  a month ago

  Patient access liaison

  remote, United States

  $155k – $195k/yrFull TimeSenior (5+ years)

  Apply
• 

  Pharvaris

  a month ago

  Care specialist

  remote, United States

  $110k – $150k/yrFull TimeSenior (5+ years)

  Apply

Hiring activity at Pharvaris